Maybe Roche will pay $50/share or 25% more than their initial $40/share offer. Then again, maybe not.
Look on the bright side, if Roche buys ILMN at $50/share you only lose a few cents per share for the privilege. OTOH, if Roche pulls the plug, you'll have plenty of losses to match against your fabulous profits from all your other winnings.
You're a real class act. BTW, what services do you provide on the side?